{"id":18219,"date":"2014-07-11T11:30:00","date_gmt":"2014-07-11T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/prodotti-naturali-e-cittadini-come-clienti-cosi-innoviamo-nella-farmaceutica-2\/"},"modified":"2014-07-11T11:30:00","modified_gmt":"2014-07-11T09:30:00","slug":"prodotti-naturali-e-cittadini-come-clienti-cosi-innoviamo-nella-farmaceutica-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/prodotti-naturali-e-cittadini-come-clienti-cosi-innoviamo-nella-farmaceutica-2\/","title":{"rendered":"\u201cNatural products and citizens as customers: this is how we innovate in pharmaceuticals\u201d"},"content":{"rendered":"<p>&nbsp;<span style=\"color: rgb(232, 82, 32); font-family: Arial, sans-serif; font-size: 13.5pt; text-transform: uppercase;\">THE GOOD ECONOMY<\/span><\/p>\n<p style=\"margin: 3pt 0cm; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\" class=\"MsoNormal\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family: &quot;Times New Roman&quot;;color:#060606;mso-fareast-language:IT\">With a business model based on high quality drugs, Aurora Biofarma is carving out an important market niche (10 million turnover forecast for 2015) in a sector dominated by multinationals. CEO Di Trapani &quot;But the state doesn&#039;t help us hire&quot;<\/p>\n<p><\/span><\/b><\/p>\n<p style=\"margin-bottom: 3pt; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\" class=\"MsoNormal\"><b><span style=\"font-size:10.5pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family:&quot;Times New Roman&quot;;color:#727272;mso-fareast-language: IT\">by Alexis Paparo <\/span><\/b><span style=\"font-size: 10.5pt; font-family: Arial, sans-serif; color: rgb(232, 82, 32); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">July 11, 2014<\/span> <span style=\"font-size: 10.5pt; font-family: Arial, sans-serif; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><a href=\"http:\/\/www.economyup.it\/made-in-italy\/1355_prodotti-naturali-e-cittadini-come-clienti-cosi-innoviamo-nella-farmaceutica.htm\" target=\"_blank\" rel=\"noopener\">Economy <b>up<\/b>.it Italy that wants to grow<\/a> <\/p>\n<p><\/span><\/p>\n<p style=\"margin-bottom:6.0pt\" class=\"MsoNormal\"><span style=\"font-size: large;\"><span style=\"font-family: Arial, sans-serif; color: rgb(96, 96, 96); background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\">That the sector<span class=\"apple-converted-space\">&nbsp;<\/span><\/span><strong><span style=\"font-family: Arial, sans-serif;\">pharmaceutical<\/span><\/strong><span class=\"apple-converted-space\">&nbsp;in Italy is not in excellent health it has been known for at least two decades. At least<span class=\"apple-converted-space\">&nbsp;<\/span><\/span><strong><span style=\"font-family: Arial, sans-serif;\">thirteen closed or decommissioned research and production centers<\/span><\/strong><span class=\"apple-converted-space\"><b>&nbsp;<\/b><\/span>since 1998, especially of majors such as Pfizer, Novartis, Sanofi Aventis. Yet i<span class=\"apple-converted-space\">&nbsp;<\/span><strong><span style=\"font-family: Arial, sans-serif;\">numbers<\/span><\/strong>, which make Italy second only to Germany for the value of pharmaceutical production in Europe, are very respectable:<span class=\"apple-converted-space\">&nbsp;<\/span><strong><span style=\"font-family: Arial, sans-serif;\">174 factories, 62,300 employees<\/span><\/strong><span class=\"apple-converted-space\">&nbsp;(90% graduates or graduates),<span class=\"apple-converted-space\">&nbsp;<\/span><\/span><strong><span style=\"font-family: Arial, sans-serif;\">28 billion of production<\/span><\/strong>, of which 71 per cent is destined for the foreign market.<span style=\"font-family: Arial, sans-serif; color: rgb(96, 96, 96);\"><br \/> <span","protected":false},"excerpt":{"rendered":"<p>&nbsp;LA BUONA ECONOMIA Con un modello di business basato sui farmaci di alta qualit&agrave;, Aurora Biofarma si sta ritagliando un&#8217;importante nicchia di mercato (10 milioni di fatturato previsti per il 2015) in un settore dominato dalle multinazionali. L&#8217;ad Di Trapani &quot;Ma lo Stato non ci aiuta ad assumere&quot; di Alexis Paparo 11 Luglio 2014 Economy &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18219","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18219"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18219\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}